Cargando…
PCDHB15 as a potential tumor suppressor and epigenetic biomarker for breast cancer
Breast cancer is among the most frequently diagnosed cancer types and the leading cause of cancer-related death in women. The mortality rate of patients with breast cancer is currently increasing, perhaps due to a lack of early screening tools. In the present study, using The Cancer Genome Atlas (TC...
Autores principales: | Chiang, Ching-Chung, Lin, Guan-Ling, Yang, Shu-Yi, Tu, Chi-Wen, Huang, Wen-Long, Wei, Chun-Feng, Wang, Feng-Chi, Lin, Pin-Ju, Huang, Wan-Hong, Chuang, Yu-Ming, Lee, Yu-Ting, Yeh, Chia-Chou, Chan, Michael W.Y., Hsu, Yu-Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855166/ https://www.ncbi.nlm.nih.gov/pubmed/35261631 http://dx.doi.org/10.3892/ol.2022.13237 |
Ejemplares similares
-
Epigenetically regulated PCDHB15 impairs aggressiveness of metastatic melanoma cells
por: Carrier, Arnaud, et al.
Publicado: (2022) -
FOSB–PCDHB13 Axis Disrupts the Microtubule Network in Non-Small Cell Lung Cancer
por: Ting, Chen-Hung, et al.
Publicado: (2019) -
Functional test of PCDHB11, the most human-specific neuronal surface protein
por: de Freitas, Guilherme Braga, et al.
Publicado: (2016) -
Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma
por: Yeh, Chia-Ming, et al.
Publicado: (2015) -
Epigenetic silencing of the NR4A3 tumor suppressor, by aberrant JAK/STAT signaling, predicts prognosis in gastric cancer
por: Yeh, Chung-Min, et al.
Publicado: (2016)